EDIUNET Free equity investment tool of Japanese companies

Companies Cart
@
Financial Statement Details
Annual
First quarter
Second quarter
Third quarter
Sponsored Link
Related Company
@ kyowa Hakko Kirin +
@ KANEKA +
@ MANDOM +
@ 栄研化学 +
@ Dainippon Sumitomo Pharma +
@ TAIYO HOLDINGS +
@ 千寿製薬 +
@ Hitachi Chemical +
@ 積水樹脂 +
@ NATOCO +
@ Noevir Holdings +
@ KUMIAI CHEMICAL INDUSTRY +
@ Central Glass +
@ 小林製薬 +
@ Dr.Ci:Labo +
EDIUNET Related Ranking
EDIUNET
EDIUNET Credit Rating
EDIUNET Industry Avg
EDIUNET Prefectures
Yuho! Industry
EDIUNET Rating News
Prev « 2024-04 » Next
Mon Tue Wed Thu Fri Sat Sun
1
-
2
-
3
-
4
-
5
-
6
-
7
-
8
-
9
-
10
-
11
-
12
-
13
-
14
-
15
-
16
-
17
-
18
-
19
-
20
-
21
-
22
-
23
-
24
-
25
-
26
-
27
-
28
-
29
-
30
-
[Update list]
1/28 Retail Trade (CAWACHI:A etc...
1/27 Banks (The Awa Bank:BBB→A)
1/23 Chemicals (Milbon:AA→AAA)
1/21 Glass & Ceramics Products (..
1/21 Machinery (TSUDAKOMA:C)
1/21 Other Services (Netindex.:CC)
1/20 Other Products (Kurogane Kos..
1/20 Wholesale Trade (リーバイ・..
1/20 Other Services (川崎地質:BB→..
1/17 Chemicals (Kawaguchi Chemica..
 RSS
 Company RSS
 Daily RSS
Sponsored Link
Recently Download Chart
Nittetsu Mining
graph
クラリオン
graph
クラリオン
graph
クラリオン
graph
クラリオン
graph

Financial Statement Details: SAWAI PHARMACEUTICAL (Annual )

Two or more periods are displayed by each of subject collectively.Two or more companies can be compared and financial statement data can also be downloaded.

【Analysis Menu】 @Outline @Statement @Rating @Indicator @Download

Sponsored Link

*Free Download Financial Statement data

U-Chart(pie chart)2009-03-312010-03-312011-03-312012-03-312013-03-31
  • Cash etc.
  • Other Current Assets
  • Tangible Assets
  • Intangible Assets
  • Investment etc.
  • Current Liabilities
  • Fixed Liabilities
  • Capital stock
  • Capital surplus etc.
*IN(*Right half), OUT(*Left half), BALANCE(*Net Assets)
[BS] 2009-03-31
 *  Total: ¥ 72 B
 *  Net: ¥ 41 B
 (Ratio: 57.67%)
[BS] 2010-03-31
 *  Total: ¥ 81 B
 *  Net: ¥ 46 B
 (Ratio: 56.94%)
[BS] 2011-03-31
 *  Total: ¥ 117 B
 *  Net: ¥ 50 B
 (Ratio: 43.45%)
[BS] 2012-03-31
 *  Total: ¥ 123 B
 *  Net: ¥ 58 B
 (Ratio: 47.47%)
[BS] 2013-03-31
 *  Total: ¥ 127 B
 *  Net: ¥ 61 B
 (Ratio: 48.09%)
Financial Statement Details2009-03-312010-03-312011-03-312012-03-312013-03-31
Cash etc. ¥ 6 B ¥ 9 B ¥ 30 B ¥ 26 B ¥ 20 B
Other Current Assets ¥ 32 B ¥ 38 B ¥ 46 B ¥ 53 B ¥ 58 B
Tangible Assets ¥ 31 B ¥ 31 B ¥ 32 B ¥ 33 B ¥ 44 B
Intangible Assets ¥ 598 M ¥ 478 M ¥ 1 B ¥ 2 B ¥ 1 B
Investment etc. ¥ 947 M ¥ 957 M ¥ 6 B ¥ 7 B ¥ 2 B
Total Assets ¥ 72 B ¥ 81 B ¥ 117 B ¥ 123 B ¥ 127 B
Current Liabilities ¥ 20 B ¥ 25 B ¥ 25 B ¥ 26 B ¥ 30 B
Fixed Liabilities ¥ 9 B ¥ 9 B ¥ 40 B ¥ 37 B ¥ 36 B
Capital stock ¥ 11 B ¥ 11 B ¥ 11 B ¥ 11 B ¥ 11 B
Capital surplus etc. ¥ 30 B ¥ 34 B ¥ 39 B ¥ 46 B ¥ 49 B
Liabilities and net assets ¥ 72 B ¥ 81 B ¥ 117 B ¥ 123 B ¥ 127 B
U-Chart(pie chart)2009-03-312010-03-312011-03-312012-03-312013-03-31
  • Sales
  • Cost of Sales
  • Other income
  • SG&A
  • Other expenses
  • Net income
*IN(*Right half), OUT(*Left half), BALANCE(*Net Income)
[PL] 2009-03-31
 *  Sales: ¥ 44 B
 *  Income: ¥ 2 B
 (Ratio: 5.51%)
[PL] 2010-03-31
 *  Sales: ¥ 50 B
 *  Income: ¥ 4 B
 (Ratio: 9.95%)
[PL] 2011-03-31
 *  Sales: ¥ 63 B
 *  Income: ¥ 7 B
 (Ratio: 11.25%)
[PL] 2012-03-31
 *  Sales: ¥ 67 B
 *  Income: ¥ 9 B
 (Ratio: 13.35%)
[PL] 2013-03-31
 *  Sales: ¥ 80 B
 *  Income: ¥ 12 B
 (Ratio: 14.93%)
Financial Statement Details2009-03-312010-03-312011-03-312012-03-312013-03-31
Sales ¥ 44 B ¥ 50 B ¥ 63 B ¥ 67 B ¥ 80 B
Cost of Sales ¥ 25 B ¥ 26 B ¥ 33 B ¥ 34 B ¥ 42 B
Gross profit ¥ 19 B ¥ 23 B ¥ 30 B ¥ 33 B ¥ 37 B
Other income ¥ 131 M ¥ 172 M ¥ 883 M ¥ 462 M ¥ 1 B
SG&A ¥ 14 B ¥ 15 B ¥ 16 B ¥ 18 B ¥ 20 B
Other expenses ¥ 2 B ¥ 3 B ¥ 7 B ¥ 6 B ¥ 6 B
Net income ¥ 2 B ¥ 4 B ¥ 7 B ¥ 9 B ¥ 12 B
U-Chart(pie chart)2009-03-312010-03-312011-03-312012-03-312013-03-31
  • Operating CF
  • Investment CF
  • Financial CF
  • Foreign Exchange Effects
  • Net Change in Cash
*IN(*Right half), OUT(*Left half), BALANCE(*Net Change in Cash)
[CF] 2009-03-31
 *  OCF: ¥ 3 B
 *  Cash: ¥ +1 B
[CF] 2010-03-31
 *  OCF: ¥ 7 B
 *  Cash: ¥ +2 B
[CF] 2011-03-31
 *  OCF: ¥ 5 B
 *  Cash: ¥ +10 B
[CF] 2012-03-31
 *  OCF: ¥ 7 B
 *  Cash: ¥ +864 M
[CF] 2013-03-31
 *  OCF: ¥ 12 B
 *  Cash: ¥ -86 M
Financial Statement Details2009-03-312010-03-312011-03-312012-03-312013-03-31
Operating CF ¥ 3 B ¥ 7 B ¥ 5 B ¥ 7 B ¥ 12 B
Investment CF ¥ -3 B ¥ -5 B ¥ -20 B ¥ -2 B ¥ -1 B
Financial CF ¥ 1 B ¥ 347 M ¥ 24 B ¥ -4 B ¥ -10 B
Foreign Exchange Effects - - - - -
Net Change in Cash ¥ 1 B ¥ 2 B ¥ 10 B ¥ 864 M ¥ -86 M
U-Chart(pie chart)2009-03-312010-03-312011-03-312012-03-312013-03-31
  • Issuance of new shares
  • Dividends from surplus
  • Net income
  • Purchase of treasury stock
  • Other Change in Stockholders Equity
  • Other Change in Net Assets
  • Net Change in Net Assets
*IN(*Right half), OUT(*Left half), BALANCE(*Net Change in Net Assets)
[SS] 2009-03-31
 *  Income: ¥ 2 B
 *  Net: ¥ +1 B
[SS] 2010-03-31
 *  Income: ¥ 4 B
 *  Net: ¥ +4 B
[SS] 2011-03-31
 *  Income: ¥ 7 B
 *  Net: ¥ +4 B
[SS] 2012-03-31
 *  Income: ¥ 9 B
 *  Net: ¥ +7 B
[SS] 2013-03-31
 *  Income: ¥ 12 B
 *  Net: ¥ +2 B
Financial Statement Details2009-03-312010-03-312011-03-312012-03-312013-03-31
Issuance of new shares - - ¥ 491 M ¥ 136 M ¥ 91 M
Dividends from surplus ¥ -863 M ¥ -863 M ¥ -1 B ¥ -2 B ¥ -2 B
Net income ¥ 2 B ¥ 4 B ¥ 7 B ¥ 9 B ¥ 12 B
Purchase of treasury stock ¥ -1 M - - - ¥ -6 B
Other Change in Stockholders Equity ¥ -1 M - - - ¥ -1 M
Other Change in Net Assets ¥ -73 M ¥ 433 M ¥ -1 B ¥ 604 M ¥ -380 M
Net Change in Net Assets ¥ 1 B ¥ 4 B ¥ 4 B ¥ 7 B ¥ 2 B
U-Chart(pie chart)2009-03-312010-03-312011-03-312012-03-312013-03-31
  • Cash etc.
  • Other Current Assets
  • Tangible Assets
  • Intangible Assets
  • Investment etc.
  • Current Liabilities
  • Fixed Liabilities
  • Capital stock
  • Capital surplus etc.
*IN(*Right half), OUT(*Left half), BALANCE(*Net Assets)
[BS] 2009-03-31
 *  Total: ¥ 63 B
 *  Net: ¥ 37 B
 (Ratio: 58.43%)
[BS] 2010-03-31
 *  Total: ¥ 72 B
 *  Net: ¥ 41 B
 (Ratio: 56.78%)
[BS] 2011-03-31
 *  Total: ¥ 109 B
 *  Net: ¥ 47 B
 (Ratio: 43.20%)
[BS] 2012-03-31
 *  Total: ¥ 113 B
 *  Net: ¥ 52 B
 (Ratio: 46.46%)
[BS] 2013-03-31
 *  Total: ¥ 126 B
 *  Net: ¥ 60 B
 (Ratio: 47.72%)
Financial Statement Details2009-03-312010-03-312011-03-312012-03-312013-03-31
Cash etc. ¥ 4 B ¥ 6 B ¥ 27 B ¥ 23 B ¥ 17 B
Other Current Assets ¥ 30 B ¥ 37 B ¥ 45 B ¥ 52 B ¥ 59 B
Tangible Assets ¥ 25 B ¥ 25 B ¥ 25 B ¥ 26 B ¥ 43 B
Intangible Assets ¥ 504 M ¥ 403 M ¥ 1 B ¥ 1 B ¥ 1 B
Investment etc. ¥ 2 B ¥ 2 B ¥ 9 B ¥ 9 B ¥ 3 B
Total Assets ¥ 63 B ¥ 72 B ¥ 109 B ¥ 113 B ¥ 126 B
Current Liabilities ¥ 17 B ¥ 22 B ¥ 22 B ¥ 23 B ¥ 29 B
Fixed Liabilities ¥ 8 B ¥ 8 B ¥ 39 B ¥ 37 B ¥ 36 B
Capital stock ¥ 11 B ¥ 11 B ¥ 11 B ¥ 11 B ¥ 11 B
Capital surplus etc. ¥ 25 B ¥ 29 B ¥ 35 B ¥ 40 B ¥ 48 B
Liabilities and net assets ¥ 63 B ¥ 72 B ¥ 109 B ¥ 113 B ¥ 126 B
U-Chart(pie chart)2009-03-312010-03-312011-03-312012-03-312013-03-31
  • Sales
  • Cost of Sales
  • Other income
  • SG&A
  • Other expenses
  • Net income
*IN(*Right half), OUT(*Left half), BALANCE(*Net Income)
[PL] 2009-03-31
 *  Sales: ¥ 43 B
 *  Income: ¥ 1 B
 (Ratio: 4.60%)
[PL] 2010-03-31
 *  Sales: ¥ 49 B
 *  Income: ¥ 4 B
 (Ratio: 8.93%)
[PL] 2011-03-31
 *  Sales: ¥ 63 B
 *  Income: ¥ 6 B
 (Ratio: 10.77%)
[PL] 2012-03-31
 *  Sales: ¥ 68 B
 *  Income: ¥ 7 B
 (Ratio: 10.99%)
[PL] 2013-03-31
 *  Sales: ¥ 79 B
 *  Income: ¥ 16 B
 (Ratio: 20.25%)
Financial Statement Details2009-03-312010-03-312011-03-312012-03-312013-03-31
Sales ¥ 43 B ¥ 49 B ¥ 63 B ¥ 68 B ¥ 79 B
Cost of Sales ¥ 26 B ¥ 28 B ¥ 36 B ¥ 38 B ¥ 43 B
Gross profit ¥ 16 B ¥ 21 B ¥ 27 B ¥ 29 B ¥ 36 B
Other income ¥ 134 M ¥ 183 M ¥ 1 B ¥ 328 M ¥ 5 B
SG&A ¥ 13 B ¥ 14 B ¥ 15 B ¥ 17 B ¥ 19 B
Other expenses ¥ 1 B ¥ 2 B ¥ 6 B ¥ 5 B ¥ 6 B
Net income ¥ 1 B ¥ 4 B ¥ 6 B ¥ 7 B ¥ 16 B
U-Chart(pie chart)2009-03-312010-03-312011-03-312012-03-312013-03-31
  • Issuance of new shares
  • Dividends from surplus
  • Net income
  • Purchase of treasury stock
  • Other Change in Stockholders Equity
  • Other Change in Net Assets
  • Net Change in Net Assets
*IN(*Right half), OUT(*Left half), BALANCE(*Net Change in Net Assets)
[SS] 2009-03-31
 *  Income: ¥ 1 B
 *  Net: ¥ +1 B
[SS] 2010-03-31
 *  Income: ¥ 4 B
 *  Net: ¥ +3 B
[SS] 2011-03-31
 *  Income: ¥ 6 B
 *  Net: ¥ +6 B
[SS] 2012-03-31
 *  Income: ¥ 7 B
 *  Net: ¥ +5 B
[SS] 2013-03-31
 *  Income: ¥ 16 B
 *  Net: ¥ +7 B
Financial Statement Details2009-03-312010-03-312011-03-312012-03-312013-03-31
Issuance of new shares - - ¥ 491 M ¥ 136 M ¥ 91 M
Dividends from surplus ¥ -863 M ¥ -863 M ¥ -1 B ¥ -2 B ¥ -2 B
Net income ¥ 1 B ¥ 4 B ¥ 6 B ¥ 7 B ¥ 16 B
Purchase of treasury stock ¥ -1 M - - - ¥ -6 B
Other Change in Stockholders Equity ¥ -2 M ¥ -1 M - - -
Other Change in Net Assets ¥ -63 M ¥ 186 M ¥ -3 M ¥ 58 M ¥ 157 M
Net Change in Net Assets ¥ 1 B ¥ 3 B ¥ 6 B ¥ 5 B ¥ 7 B

Consolidated :Balance sheet (Annual ) 2008-03-312009-03-312010-03-312011-03-312012-03-312013-03-31
  Net assets¥ 40 B¥ 41 B¥ 46 B¥ 50 B¥ 58 B¥ 61 B
   Cash and deposits¥ 5 B¥ 6 B¥ 9 B¥ 30 B¥ 26 B¥ 20 B
   Notes and accounts receivable-trade¥ 15 B¥ 17 B¥ 18 B¥ 23 B¥ 25 B¥ 26 B
    Merchandise and finished goods¥ 6 B¥ 9 B¥ 11 B¥ 14 B¥ 15 B
     Raw materials and supplies¥ 3 B¥ 4 B¥ 5 B¥ 6 B¥ 7 B
     Work in process¥ 3 B¥ 3 B¥ 4 B¥ 4 B¥ 6 B
   Deferred tax assets¥ 709 M¥ 1 B¥ 1 B¥ 1 B¥ 1 B¥ 1 B
    Allowance for doubtful accounts¥ -22 M¥ -25 M¥ -10 M¥ -21 M¥ -21 M¥ -12 M
   Other¥ 452 M¥ 231 M¥ 144 M¥ 397 M¥ 618 M¥ 1 B
   Current assets¥ 35 B¥ 38 B¥ 48 B¥ 77 B¥ 80 B¥ 79 B
    Buildings and structures¥ 24 B¥ 28 B¥ 28 B¥ 29 B¥ 30 B¥ 35 B
     Accumulated depreciation¥ -8 B¥ -9 B¥ -10 B¥ -10 B¥ -12 B¥ -12 B
     Buildings and structures, net¥ 15 B¥ 18 B¥ 18 B¥ 18 B¥ 17 B¥ 22 B
    Machinery, equipment and vehicles¥ 14 B¥ 16 B¥ 17 B¥ 19 B¥ 20 B¥ 27 B
     Accumulated depreciation¥ -8 B¥ -9 B¥ -11 B¥ -12 B¥ -13 B¥ -14 B
     Machinery, equipment and vehicles, net¥ 5 B¥ 6 B¥ 6 B¥ 7 B¥ 7 B¥ 12 B
    Land¥ 4 B¥ 5 B¥ 5 B¥ 4 B¥ 4 B¥ 6 B
    Lease assets¥ 34 M¥ 38 M¥ 45 M¥ 36 M¥ 95 M
     Accumulated depreciation¥ -8 M¥ -19 M¥ -30 M¥ -16 M¥ -19 M
     Lease assets, net¥ 26 M¥ 18 M¥ 14 M¥ 19 M¥ 75 M
    Construction in progress¥ 1 B¥ 31 M¥ 569 M¥ 494 M¥ 2 B¥ 59 M
     Other¥ 3 B¥ 3 B¥ 4 B¥ 4 B¥ 5 B¥ 5 B
      Accumulated depreciation¥ -2 B¥ -2 B¥ -3 B¥ -3 B¥ -3 B¥ -4 B
      Other, net¥ 1 B¥ 1 B¥ 1 B¥ 1 B¥ 1 B¥ 1 B
    Property, plant and equipment¥ 28 B¥ 31 B¥ 31 B¥ 32 B¥ 33 B¥ 44 B
    Intangible assets¥ 762 M¥ 598 M¥ 478 M¥ 1 B¥ 2 B¥ 1 B
     Investment securities¥ 820 M¥ 544 M¥ 658 M¥ 5 B¥ 6 B¥ 1 B
     Long-term loans receivable¥ 216 M¥ 98 M¥ 54 M¥ 17 M¥ 5 M-
     Long-term prepaid expenses¥ 90 M¥ 70 M¥ 42 M¥ 60 M¥ 41 M¥ 31 M
     Deferred tax assets¥ 31 M-¥ 27 M
     Other¥ 261 M¥ 228 M¥ 247 M¥ 379 M¥ 360 M¥ 316 M
      Allowance for doubtful accounts¥ -53 M¥ -28 M¥ -46 M¥ -64 M¥ -40 M¥ -25 M
    Investments and other assets¥ 1 B¥ 945 M¥ 956 M¥ 6 B¥ 7 B¥ 2 B
   Noncurrent assets¥ 30 B¥ 33 B¥ 33 B¥ 39 B¥ 42 B¥ 48 B
  Assets¥ 66 B¥ 72 B¥ 81 B¥ 117 B¥ 123 B¥ 127 B
   Notes and accounts payable-trade¥ 6 B¥ 6 B¥ 10 B¥ 9 B¥ 10 B¥ 11 B
   Lease obligations¥ 10 M¥ 12 M¥ 7 M¥ 7 M¥ 18 M
    Provision for bonuses¥ 813 M¥ 871 M¥ 1 B¥ 1 B¥ 1 B¥ 1 B
    Provision for directors' bonuses¥ 44 M¥ 47 M¥ 82 M¥ 60 M¥ 78 M¥ 82 M
    Provision for sales rebates¥ 263 M¥ 344 M¥ 509 M¥ 792 M¥ 883 M¥ 723 M
    Provision for sales returns¥ 154 M¥ 128 M¥ 102 M¥ 125 M¥ 64 M¥ 63 M
    Accounts payable-other¥ 3 B¥ 6 B¥ 4 B¥ 7 B¥ 6 B¥ 9 B
    Income taxes payable¥ 821 M¥ 1 B¥ 2 B¥ 3 B¥ 4 B¥ 3 B
    Short-term loans payable¥ 4 B¥ 5 B¥ 6 B¥ 2 B¥ 2 B¥ 2 B
   Other¥ 207 M¥ 236 M¥ 279 M¥ 352 M¥ 550 M¥ 670 M
   Current liabilities¥ 17 B¥ 20 B¥ 25 B¥ 25 B¥ 26 B¥ 30 B
    Bonds with subscription rights to shares¥ 30 B¥ 30 B¥ 30 B
    Long-term loans payable¥ 7 B¥ 8 B¥ 8 B¥ 8 B¥ 5 B¥ 3 B
    Provision for retirement benefits¥ 169 M¥ 116 M¥ 92 M¥ 90 M¥ 93 M¥ 89 M
    Provision for directors' retirement benefits¥ 387 M¥ 206 M¥ 270 M¥ 339 M¥ 425 M¥ 587 M
   Lease obligations¥ 20 M¥ 11 M¥ 10 M¥ 14 M¥ 62 M
    Long-term deposits received¥ 711 M¥ 779 M¥ 938 M¥ 1 B¥ 1 B
    Deferred tax liabilities¥ 207 M¥ 138 M¥ 185 M¥ 166 M¥ 82 M¥ 75 M
   Noncurrent liabilities¥ 8 B¥ 9 B¥ 9 B¥ 40 B¥ 37 B¥ 36 B
  Liabilities¥ 26 B¥ 30 B¥ 34 B¥ 66 B¥ 64 B¥ 66 B
   Capital stock¥ 11 B¥ 11 B¥ 11 B¥ 11 B¥ 11 B¥ 11 B
    Capital surplus¥ 11 B¥ 11 B¥ 11 B¥ 12 B¥ 12 B¥ 12 B
    Retained earnings¥ 15 B¥ 16 B¥ 20 B¥ 26 B¥ 33 B¥ 43 B
   Treasury stock¥ -1 M¥ -2 M¥ -3 M¥ -3 M¥ -3 M¥ -6 B
   Shareholders' equity¥ 38 B¥ 39 B¥ 44 B¥ 50 B¥ 57 B¥ 61 B
   Valuation difference on available-for-sale securities¥ 234 M¥ 86 M¥ 153 M¥ 110 M¥ 715 M¥ 334 M
   Valuation and translation adjustments¥ 234 M¥ 86 M¥ 153 M¥ 110 M¥ 715 M¥ 334 M
  Subscription rights to shares¥ 82 M¥ 201 M¥ 108 M¥ 70 M¥ 45 M
  Minority interests¥ 1 B¥ 1 B¥ 1 B¥ 9 M¥ 9 M¥ 9 M
 Liabilities and net assets¥ 66 B¥ 72 B¥ 81 B¥ 117 B¥ 123 B¥ 127 B
   Negative goodwill¥ 41 M¥ 38 M¥ 26 M¥ 12 M-
   Inventories¥ 13 B
    Other¥ 642 M
Consolidated :Income statement (Annual ) 2008-03-312009-03-312010-03-312011-03-312012-03-312013-03-31
   Net sales¥ 37 B¥ 44 B¥ 50 B¥ 63 B¥ 67 B¥ 80 B
 Operating income¥ 4 B¥ 4 B¥ 8 B¥ 13 B¥ 15 B¥ 17 B
 Ordinary income¥ 3 B¥ 4 B¥ 8 B¥ 12 B¥ 15 B¥ 17 B
 Net income¥ 1 B¥ 2 B¥ 4 B¥ 7 B¥ 9 B¥ 12 B
 Comprehensive income¥ 7 B¥ 9 B¥ 11 B
   Cost of sales¥ 20 B¥ 25 B¥ 26 B¥ 33 B¥ 34 B¥ 42 B
    Selling, general and administrative expenses¥ 13 B¥ 14 B¥ 15 B¥ 16 B¥ 18 B¥ 20 B
 Gross profit¥ 17 B¥ 19 B¥ 23 B¥ 30 B¥ 33 B¥ 37 B
  Interest income¥ 5 M¥ 4 M¥ 1 M¥ 88 M¥ 153 M¥ 152 M
  Dividends income¥ 11 M¥ 12 M¥ 11 M¥ 50 M¥ 177 M¥ 209 M
  Amortization of negative goodwill¥ 11 M¥ 11 M¥ 13 M¥ 13 M¥ 12 M-
  Compensation income¥ 11 M¥ 25 M¥ 59 M¥ 61 M¥ 16 M¥ 14 M
  Subsidy income¥ 10 M¥ 23 M¥ 38 M¥ 29 M¥ 42 M¥ 26 M
  Reversal of allowance for doubtful accounts¥ 21 M¥ 9 M¥ 16 M¥ 5 M¥ 2 M¥ 9 M
  Other¥ 27 M¥ 45 M¥ 31 M¥ 36 M¥ 56 M¥ 84 M
  Non-operating income¥ 98 M¥ 131 M¥ 172 M¥ 285 M¥ 462 M¥ 497 M
  Interest expenses¥ 191 M¥ 164 M¥ 210 M¥ 215 M¥ 163 M¥ 130 M
  Financing expenses¥ 97 M¥ 32 M¥ 29 M¥ 109 M¥ 27 M
  Depreciation-¥ 35 M
  Loss on sales of accounts receivable¥ 36 M¥ 42 M
  Other¥ 35 M¥ 58 M¥ 28 M¥ 117 M¥ 97 M¥ 44 M
  Non-operating expenses¥ 734 M¥ 320 M¥ 284 M¥ 1 B¥ 370 M¥ 280 M
  Gain on sales of investment securities-¥ 653 M
  Subsidy-¥ 200 M
  Extraordinary income¥ 969 K¥ 598 M-¥ 853 M
  Impairment loss-¥ 133 M-
  Loss on retirement of noncurrent assets¥ 24 M¥ 76 M¥ 34 M¥ 126 M¥ 34 M¥ 357 M
  Extraordinary loss¥ 284 M¥ 159 M¥ 34 M¥ 1 B¥ 167 M¥ 357 M
 Income before income taxes¥ 3 B¥ 4 B¥ 8 B¥ 12 B¥ 14 B¥ 18 B
 Income taxes¥ 1 B¥ 1 B¥ 3 B¥ 4 B¥ 5 B¥ 6 B
  Income taxes-current¥ 1 B¥ 2 B¥ 3 B¥ 4 B¥ 6 B¥ 5 B
  Income taxes-deferred¥ -164 M¥ -610 M¥ -432 M¥ -14 M¥ -263 M¥ 171 M
 Income before minority interests¥ 7 B¥ 9 B¥ 12 B
 Minority interests in income¥ 173 M¥ 281 M¥ 250 M¥ 141 M--
  Valuation difference on available-for-sale securities¥ -43 M¥ 605 M¥ -380 M
  Other comprehensive income¥ -43 M¥ 605 M¥ -380 M
   Comprehensive income attributable to owners of the parent¥ 7 B¥ 9 B¥ 11 B
   Comprehensive income attributable to minority interests¥ 141 M--
  Bond issuance cost¥ 806 M-
  Gain on sales of noncurrent assets¥ 969 K¥ 598 M-
  Loss on sales of noncurrent assets¥ 2 M¥ 3 M¥ 45 M-
  Loss on valuation of investment securities¥ 50 M¥ 77 M¥ 840 M-
  Compensation expenses¥ 12 M
  Provision of allowance for doubtful accounts of golf club membership¥ 1 M
  Loss on abandonment of inventories¥ 507 M
Consolidated :Cash flow statement (Annual ) 2008-03-312009-03-312010-03-312011-03-312012-03-312013-03-31
  Subtotal¥ 11 B¥ 4 B¥ 10 B¥ 10 B¥ 13 B¥ 18 B
   Depreciation and amortization¥ 2 B¥ 2 B¥ 3 B¥ 3 B¥ 3 B¥ 3 B
   Impairment loss-¥ 133 M-
   Amortization of goodwill¥ 11 M¥ 65 M-
   Increase (decrease) in allowance for doubtful accounts¥ -23 M¥ -20 M¥ 2 M¥ 28 M¥ -23 M¥ -23 M
   Interest and dividends income¥ -17 M¥ -16 M¥ -13 M¥ -139 M¥ -331 M¥ -362 M
   Interest expenses¥ 191 M¥ 164 M¥ 210 M¥ 215 M¥ 163 M¥ 130 M
   Decrease (increase) in notes and accounts receivable-trade¥ 1 B¥ -1 B¥ -1 B¥ -4 B¥ -2 B¥ -1 B
   Decrease (increase) in inventories¥ 267 M¥ -88 M¥ -4 B¥ -3 B¥ -4 B¥ -3 B
   Increase (decrease) in notes and accounts payable-trade¥ 2 B¥ -448 M¥ 3 B¥ -560 M¥ 872 M¥ 1 B
   Loss (gain) on sales of investment securities-¥ -653 M
   Amortization of negative goodwill¥ -11 M¥ -11 M¥ -13 M¥ -13 M¥ -12 M-
   Increase (decrease) in provision for bonuses¥ 105 M¥ 58 M¥ 208 M¥ 5 M¥ 65 M¥ 151 M
   Increase (decrease) in provision for directors' retirement benefits¥ 6 M¥ -180 M¥ 64 M¥ 68 M¥ 85 M¥ 162 M
   Increase (decrease) in provision for directors' bonuses¥ -2 M¥ 2 M¥ 35 M¥ -22 M¥ 18 M¥ 3 M
   Increase (decrease) in provision for retirement benefits¥ -16 M¥ -53 M¥ -23 M¥ -2 M¥ 3 M¥ -4 M
   Increase (decrease) in provision for sales returns¥ 77 M¥ -26 M¥ -25 M¥ 23 M¥ -60 M-
   Loss on retirement of noncurrent assets¥ 24 M¥ 76 M¥ 31 M¥ 126 M¥ 29 M¥ 357 M
   Increase (decrease) in accounts payable-other¥ 838 M¥ -362 M¥ 428 M¥ 2 B¥ 20 M¥ 631 M
   Decrease (increase) in long-term prepaid expenses¥ -34 M¥ 19 M¥ 28 M¥ -18 M¥ 19 M¥ 11 M
   Other, net¥ 225 M¥ 453 M¥ 299 M¥ -550 M¥ 360 M¥ -53 M
  Interest and dividends income received¥ 17 M¥ 16 M¥ 13 M¥ 51 M¥ 181 M¥ 212 M
  Interest expenses paid¥ -188 M¥ -168 M¥ -209 M¥ -206 M¥ -159 M¥ -126 M
  Income taxes paid¥ -1 B¥ -1 B¥ -2 B¥ -4 B¥ -5 B¥ -6 B
  Net cash provided by (used in) operating activities¥ 9 B¥ 3 B¥ 7 B¥ 5 B¥ 7 B¥ 12 B
  Purchase of property, plant and equipment¥ -6 B¥ -2 B¥ -5 B¥ -2 B¥ -3 B¥ -4 B
  Purchase of investment securities¥ -50 M¥ -5 B¥ -460 M¥ -630 M
  Proceeds from sales of investment securities-¥ 5 B
  Purchase of intangible assets¥ -281 M¥ -119 M¥ -156 M¥ -594 M¥ -1 B¥ -595 M
  Net decrease (increase) in time deposits¥ -11 B¥ 5 B¥ 6 B
  Collection of long-term loans receivable¥ 20 M¥ 187 M¥ 44 M¥ 37 M¥ 12 M¥ 5 M
  Other, net¥ 750 K¥ 445 K-¥ -17 M-
  Net cash provided by (used in) investing activities¥ -6 B¥ -3 B¥ -5 B¥ -20 B¥ -2 B¥ -1 B
  Proceeds from long-term loans payable¥ 1 B¥ 3 B¥ 2 B¥ 3 B-¥ 600 M
  Repayment of long-term loans payable¥ -3 B¥ -2 B¥ -2 B¥ -2 B¥ -2 B¥ -2 B
  Purchase of treasury stock¥ -208 K¥ -1 M---¥ -6 B
  Cash dividends paid¥ -863 M¥ -863 M¥ -863 M¥ -1 B¥ -2 B¥ -2 B
  Proceeds from sales of treasury stock-¥ 134 M
  Proceeds from issuance of stock resulting from exercise of subscription rights to shares¥ 491 M¥ 136 M¥ 91 M
  Other, net¥ 2 M¥ -7 M¥ -11 M¥ -11 M¥ -7 M¥ -10 M
  Net cash provided by (used in) financing activities¥ -4 B¥ 1 B¥ 347 M¥ 24 B¥ -4 B¥ -10 B
 Effect of exchange rate change on cash and cash equivalents--
 Net increase (decrease) in cash and cash equivalents¥ -1 B¥ 1 B¥ 2 B¥ 10 B¥ 864 M¥ -86 M
 Cash and cash equivalents¥ 5 B¥ 6 B¥ 9 B¥ 19 B¥ 20 B¥ 20 B
   Loss (gain) on valuation of investment securities¥ 50 M¥ 77 M¥ 840 M-
   Bond issuance cost¥ 806 M-
  Proceeds from sales of property, plant and equipment¥ 930 M-
  Purchase of investments in subsidiaries¥ -20 M¥ -263 M¥ -2 M¥ -1 B-
  Net increase (decrease) in short-term loans payable¥ -2 B¥ 530 M¥ 1 B¥ -4 B-
  Cash dividends paid to minority shareholders¥ -78 M¥ -17 M¥ -455 M-
  Proceeds from issuance of bonds with subscription rights to shares¥ 29 B-
  Payments into time deposits¥ -11 B
  Purchase of short-term investment securities¥ -2 M¥ -4 M
  Proceeds from sales of short-term investment securities¥ 6 M¥ 4 M
  Payments of long-term loans receivable¥ -70 M
Consolidated :Shareowners' equity (Annual ) 2008-03-312009-03-312010-03-312011-03-312012-03-312013-03-31
    Issuance of new shares-exercise of subscription rights to shares¥ 312 M¥ 86 M¥ 58 M
    Total changes of items during the period¥ 312 M¥ 86 M¥ 58 M
     Issuance of new shares-exercise of subscription rights to shares¥ 312 M¥ 86 M¥ 58 M
     Disposal of treasury stock-¥ 11 M
     Total changes of items during the period¥ 312 M¥ 86 M¥ 69 M
     Dividends from surplus¥ -863 M¥ -863 M¥ -863 M¥ -1 B¥ -2 B¥ -2 B
     Total changes of items during the period¥ 875 M¥ 1 B¥ 4 B¥ 5 B¥ 6 B¥ 9 B
    Purchase of treasury stock¥ -208 K¥ -1 M---¥ -6 B
    Disposal of treasury stock-¥ 131 M
    Total changes of items during the period¥ -208 K¥ -1 M---¥ -6 B
    Issuance of new shares-exercise of subscription rights to shares¥ 624 M¥ 173 M¥ 116 M
    Dividends from surplus¥ -863 M¥ -863 M¥ -863 M¥ -1 B¥ -2 B¥ -2 B
    Net income¥ 1 B¥ 2 B¥ 4 B¥ 7 B¥ 9 B¥ 12 B
    Purchase of treasury stock¥ -208 K¥ -1 M---¥ -6 B
    Disposal of treasury stock-¥ 142 M
    Total changes of items during the period¥ 874 M¥ 1 B¥ 4 B¥ 6 B¥ 7 B¥ 3 B
    Net changes of items other than shareholders' equity¥ -62 M¥ -147 M¥ 67 M¥ -43 M¥ 605 M¥ -380 M
    Total changes of items during the period¥ -62 M¥ -147 M¥ 67 M¥ -43 M¥ 605 M¥ -380 M
    Net changes of items other than shareholders' equity¥ -62 M¥ -147 M¥ 67 M¥ -43 M¥ 605 M¥ -380 M
    Total changes of items during the period¥ -62 M¥ -147 M¥ 67 M¥ -43 M¥ 605 M¥ -380 M
   Issuance of new shares-exercise of subscription rights to shares¥ -132 M¥ -36 M¥ -24 M
   Net changes of items other than shareholders' equity¥ 82 M¥ 119 M¥ 39 M--
   Total changes of items during the period¥ 82 M¥ 119 M¥ -93 M¥ -37 M¥ -25 M
   Net changes of items other than shareholders' equity¥ 71 M¥ -8 M¥ 247 M¥ -1 B--
   Total changes of items during the period¥ 71 M¥ -8 M¥ 247 M¥ -1 B--
   Issuance of new shares-exercise of subscription rights to shares¥ 491 M¥ 136 M¥ 91 M
   Dividends from surplus¥ -863 M¥ -863 M¥ -863 M¥ -1 B¥ -2 B¥ -2 B
   Net income¥ 1 B¥ 2 B¥ 4 B¥ 7 B¥ 9 B¥ 12 B
   Purchase of treasury stock¥ -208 K¥ -1 M---¥ -6 B
   Disposal of treasury stock-¥ 142 M
   Net changes of items other than shareholders' equity¥ 9 M¥ -73 M¥ 433 M¥ -1 B¥ 604 M¥ -380 M
   Total changes of items during the period¥ 884 M¥ 1 B¥ 4 B¥ 4 B¥ 7 B¥ 2 B
   Dividends from surplus¥ -455 M-

Free Download

*Free Download Financial Statement dataMember limited service.

[Data] Balance sheet, Income statement, Cash flow statement, Shareowners' equity (*Consolidated or Non-Consolidated. two or more terms)

Sponsored Link


Ticker Market Industry Month report Rating
@ SAWAI PHARMACEUTICAL 4555 TSE 1st Chemicals 3 Annual BBB

Related Company

@ TAKASAGO INTERNATIONAL (Sales ¥ 118 B) +
@ NATOCO (Sales ¥ 16 B) +
@ MANDOM (Sales ¥ 60 B) +
@ TOWA PHARMACEUTICAL (Sales ¥ 55 B) +
@ SAKATA INX (Sales ¥ 123 B) +
@ KUMIAI CHEMICAL INDUSTRY (Sales ¥ 49 B) +
@ Dainippon Sumitomo Pharma (Sales ¥ 347 B) +
@ Milbon (Sales ¥ 23 B) +
@ 小林製薬 (Sales ¥ 121 B) +
@ Sumitomo Bakelite (Sales ¥ 183 B) +
@ T&K TOKA (Sales ¥ 53 B) +
@ SAWAI PHARMACEUTICAL (Sales ¥ 80 B) +
@ TOAGOSEI CO (Sales ¥ 148 B) +

関連する株式投資情報

EDIUNET Caution

*Financial data might be different from the actual one. Please confirm the original, and read Caution.

*This site has obtained the information from the FSA's EDINET, Tokyo Stock Exchange's TDnet and Pay statistical data services, Fukuoka stock Exchange's Stock market capitalization, Center for Spatial Information Science's CSV Geocoding Service. The copyright of the information belongs to each corporation etc. .

▲ Go to the top ▲

  1. Guide
  2. Mobile
  3. Tablet
  4. Japanese
`EDIUNET` Copyright©2006-2024 `MAバンク` (0.154 sec.)